Search Login Register

TNFR-Fc fusion protein (etanercept) Summary

1738 relevant articles (303 outcomes, 349 trials/studies) found for this Drug

Description: reduces tumor necrosis factor activity, as well as cytokine, chemokine, and stress hormone release; used to treat SPONDYLITIS, ANKYLOSING;

Also Known As: etanercept; Enbrel; Immunex brand of etanercept; TNF receptor type II-IgG fusion protein; TNR 001 Show All >>

Key Diseases for which TNFR-Fc fusion protein is Relevant

  1. Rheumatoid Arthritis : 75 outcomes 83 studies in 492 results
  2. Psoriasis (Pustulosis Palmaris et Plantaris) : 67 outcomes 68 studies in 303 results
  3. Psoriatic Arthritis : 28 outcomes 31 studies in 170 results
  4. Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis) : 28 outcomes 19 studies in 112 results
  5. Ankylosing Spondylitis : 20 outcomes 26 studies in 119 results
Show All >>

Drugs Related to TNFR-Fc fusion protein

  1. infliximab (Remicade)
  2. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  3. TNFR-Fc fusion protein (etanercept)
  4. Methotrexate (Mexate)
  5. adalimumab (Humira)
  6. Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
  7. efalizumab
  8. alefacept (Amevive)
  9. Antirheumatic Agents (DMARD)
  10. Interleukin 1 Receptor Antagonist Protein (Anakinra)
Show All >>

Therapies Related to TNFR-Fc fusion protein

  1. Aftercare (After-Treatment)
  2. Biological Therapy
  3. Injections
  4. Transplants (Transplant)
  5. Laminectomy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2009 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.